跳到正文
原文
Biotechnology Innovation Organization· @IAmBiotech · X·· 25 天前AI 评分18
AI 导读

BIO州政府事务副总裁Brian Warren主持讨论,Tigerlily基金会CEO Maimah与IFAiArthritis CEO Tiffany Westrich-Robertson指出,越来越多证据显示处方药可负担性委员会(PDABs)未能兑现承诺,其宣称的节省很少惠及患者。讨论聚焦现有记录及真正能改善可负担性的路径。

正文

Making medicines more affordable for patients is a goal everyone shares. The question is what actually gets us there. At #BIOPACE26, @Maimah, President and CEO of the @tigerlilycares, and Tiffany Westrich-Robertson, CEO of @IFAiArthritis, dug into the growing evidence that prescription drug affordability boards (PDABs) don’t - and that the savings they promise rarely reach patients.

Hear from BIO’s Brian Warren, Vice President, State Government Affairs, who moderated, on what the record shows and what would genuinely move affordability.

来源:Biotechnology Innovation Organization · x.com